Effects of Succinylcholine on Nonintubated Thoracoscopic Surgery

Status Recruiting

Clinical Trial Summary

A safe and effective surgical environment is important for nonintubated thoracoscopic surgery. The investigators hypothesize that mini-dose succinylcholine can induce ultra-short period of apnea, by which the ventilatory responses to open pneumothorax were abolished and may facilitate rapid and satisfying collapse of the operated lung during nonintubated thoracoscopic surgery.

Clinical Trial Description

Background: Nonintubated thoracoscopic surgery is the frontier of modern minimal invasive thoracic surgery. A safe and effective surgical environment is established via an iatrogenic open pneumothorax producing the operated lung fully collapsed. However, the initial respiratory response to open pneumothorax is both tachypnea and carbon dioxide rebreathing, which would jeopardize the quality of collapse of the operated lung and delay the performance of intrathoracic vagal block. Intravenous opioid is effective to attenuate ventilatory responses but herein with risk of persistent respiratory depression.

Methods: The investigators hypothesize that mini-dose succinylcholine 0.15 mg/kg can induce ultra-short period of apnea, by which the ventilatory responses to open pneumothorax were abolished and may facilitate rapid and satisfying collapse of the operated lung during nonintubated thoracoscopic surgery. In a prospective, randomized, double-blind study design, 30 patients will be allocated to receive either succinylcholine (n=15) or placebo (n=15) in the beginning of open pneumothorax. The effectiveness of succinylcholine will be measured by the surgeon's evaluation of the quality of lung collapse, while the safety will be evaluated by determination of arterial blood gases within 20 minutes of one-lung spontaneous breathing.

Expected results: Mini-dose succinylcholine can facilitate early lung collapse without jeopardizing the ventilatory function during nonintubated thoracoscopic surgery with one-lung spontaneous breathing, which may make nonintubated thoracoscopic surgery easier and safer. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03469323
Study type	Interventional
Source	National Taiwan University Hospital
Contact	Ming-Hui Hung, MD, MSc
Phone	+886-2-23123456
Email	hung.minghui@gmail.com
Status	Recruiting
Phase	N/A
Start date	March 2018
Completion date	July 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06021249` - Comparing Innovative and Traditional Ventilation Strategies on Atelectasis and Prognosis in Elderly Patients	N/A
Terminated	`NCT03581474` - Evaluation of BAL Procedure With Ambu aScope 3 Large in Patients in an ICU Setting	N/A
Completed	`NCT02871258` - MetaNeb® Chest X-ray Study	N/A
Completed	`NCT02523755` - Evaluation of Regional Distribution of Ventilation During Labor With or Without Epidural Analgesia	Phase 4
Completed	`NCT02216006` - High Fresh Gas Flow After Intubation	N/A
Completed	`NCT02232841` - Electrical Impedance Imaging of Patients on Mechanical Ventilation	N/A
Completed	`NCT01416519` - Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation	N/A
Completed	`NCT03153592` - Effects of Mechanical Ventilation Guided by Transpulmonary Pressure on Gas Exchange During Robotic Surgery: a Pilot Study	N/A
Completed	`NCT03694665` - Monitoring Lung Recruitment Maneuver in Anesthetized Morbidly Obese	N/A
Completed	`NCT04506203` - The Accuracy of Pediatric Air Test as a Non-invasive Atelectasis Diagnostic Tool	N/A
Not yet recruiting	`NCT06296173` - Open Lung Protective Extubation Following General Anesthesia	N/A
Completed	`NCT04006665` - Role of Lung Ultrasonography in Diagnosing Atelectasis in Robotic Pelvic Surgeries
Completed	`NCT03614845` - Evaluation of Effect of Different Ventilator Mods on Atelectasis in Patients Undergoing Laparoscopic Surgery	N/A
Active, not recruiting	`NCT06075836` - AI Assisted Detection of Chest X-Rays
Completed	`NCT01993394` - Effect of Hyperoxia and Hypergravity on Lung Ventilation and Perfusion	N/A
Completed	`NCT00671723` - Dornase Alpha Versus Hypertonic Saline for Lung Atelectasis in Non-Cystic Fibrosis Patients	N/A
Completed	`NCT03378752` - Atelectasis Formation Using HFJV During Stereotactic Solid Organ Ablations
Completed	`NCT05963945` - Multi-Reader Retrospective Study Examining Carebot AI CXR 2.0.21-v2.01 Implementation in Everyday Radiology Clinical Practice
Completed	`NCT03592589` - Prevention of Atelectasis, Via High Flow Nasal Cannula to Obtain a PEP, During General Anesthesia in Children	N/A
Completed	`NCT04458623` - Air Test In Diagnosis Of Postoperative Lung Atelectasis	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.